Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS-Reference-Cited by-同舟云学术

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS

Published:2020-02 Issue:2 Volume:31 Page:191-201
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Park K.,Vansteenkiste J.,Lee K.H.,Pentheroudakis G.,Zhou C.,Prabhash K.,Seto T.,Voon P.J.,Tan D.S.W.,Yang J.C.H.,Wang J.,Babu K. Govind,Nakayama Y.,Alip A.,Chua K.L.M.,Cheng J.C.-H.,Senan S.,Ahn Y.C.,Kim T.-Y.,Ahn H.K.,Peters S.,Yoshino T.,Douillard J.-Y.

Funder

European Society for Medical Oncology

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference59 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO-ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS;Wu;Ann Oncol,2019

3. Prediction of cancer incidence and mortality in Korea, 2019;Jung;Cancer Res Treat,2019

4. Prevalence of smoking in China in 2010;Li;N Engl J Med,2011

5. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Postmus;Ann Oncol,2017

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unrevealing the therapeutic benefits of radiotherapy and consolidation immunotherapy using ctDNA-defined tumor clonality in unresectable locally advanced non-small cell lung cancer;Cancer Letters;2024-02

2. Treatment decision for recurrences in non-small cell lung cancer during or after adjuvant osimertinib: an international Delphi consensus report;Frontiers in Oncology;2024-01-23

3. Pathomic Features Reveal Immune and Molecular Evolution From Lung Preneoplasia to Invasive Adenocarcinoma;Modern Pathology;2023-12

4. Endobronchial ultrasound in diagnosing and staging of lung cancer by Acquire 22G TBNB versus regular 22G TBNA needles: A randomized clinical trial;Lung Cancer;2023-11

5. Pre-clinical lung squamous cell carcinoma mouse models to identify novel biomarkers and therapeutic interventions;Frontiers in Oncology;2023-09-25